Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Robinson

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2024
Academic Uphill Battle to Personalize Treatment for Patients With Stage II/III Triple-Negative Breast CancerMarleen Kok, Robbert-Jan Gielen, Sylvia Adams, et al.
Microbiome Research Reports|April 10, 2025
Profiling the gut and oral microbiota of hormone receptor-positive, HER2-negative metastatic breast cancer patients receiving pembrolizumab and eribulinNancy My Teng, Andrea Malfettone, Matthew J Dalby, et al.
British Journal of Cancer|April 24, 2024
Real world study of sacituzumab govitecan in metastatic triple-negative breast cancer in the United KingdomDaire Hanna, Sophie Merrick, Aruni Ghose, et al.
Cambridge Prisms. Precision Medicine|February 13, 2025
UK cancer vaccine advance - Recognising and realising opportunitiesCharles Craddock, Philip Earwaker, Matthew Fittall, et al.
JAMA Oncology|December 22, 2022
Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer: A National COVID Cancer Cross-sectional EvaluationLennard Y W Lee, Michael Tilby, Thomas Starkey, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2024
Academic Uphill Battle to Personalize Treatment for Patients With Stage II/III Triple-Negative Breast CancerMarleen Kok, Robbert-Jan Gielen, Sylvia Adams, et al.
Microbiome Research Reports|April 10, 2025
Profiling the gut and oral microbiota of hormone receptor-positive, HER2-negative metastatic breast cancer patients receiving pembrolizumab and eribulinNancy My Teng, Andrea Malfettone, Matthew J Dalby, et al.
British Journal of Cancer|April 24, 2024
Real world study of sacituzumab govitecan in metastatic triple-negative breast cancer in the United KingdomDaire Hanna, Sophie Merrick, Aruni Ghose, et al.
Cambridge Prisms. Precision Medicine|February 13, 2025
UK cancer vaccine advance - Recognising and realising opportunitiesCharles Craddock, Philip Earwaker, Matthew Fittall, et al.
JAMA Oncology|December 22, 2022
Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer: A National COVID Cancer Cross-sectional EvaluationLennard Y W Lee, Michael Tilby, Thomas Starkey, et al.
Pageof 4